Advanced Strategies against SARS-CoV-2 Variants and Future Emerging Virus Outbreaks
A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Viral Immunology, Vaccines, and Antivirals".
Deadline for manuscript submissions: closed (15 October 2024) | Viewed by 12169
Special Issue Editor
Interests: virus-host interactions; lipid rafts; gangliosides; virus receptors; RNA viruses; SARS-CoV-2 variants; antivirals; vaccines
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The COVID-19 pandemic has taught us a lot on public health strategies. Viruses mutate, spread among animal hosts in which they evolve, and sometimes acquire the capacity to infect humans. RNA viruses have exceptional mutational potential, producing a myriad of variants and quasispecies with potentially devastating pathogenic effects. DNA viruses are not left out, as evidenced by the recent detection of an abnormally high number of cases of the Monkeypox virus in Europe and in the USA. Faced with these acute public health problems, we must adapt therapeutic and vaccine strategies, design new ones, and, like viruses, we must constantly innovate. Our objective is to publish a series of articles on the mechanisms of infection of pathogenic viruses, including SARS-CoV-2 and its variants, influenza virus, Monkeypox virus or Nipah virus, and on the rational design of new prophylactic and therapeutic approaches. We hope to stimulate innovative ideas for vaccines and antiviral treatments capable of providing rapid responses in the event of new outbreaks. Research articles, reviews and perspectives are welcomed for this Special Issue.
Prof. Dr. Jacques Fantini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- SARS-CoV-2 variants
- Monkeypox virus
- Nipah virus
- virus–host interactions
- antivirals
- vaccines
- mutations
- lipid rafts
- virus receptors
- immune escape
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.